Shell Asset Management CO Arcturus Therapeutics Holdings Inc. Transaction History
Shell Asset Management CO
- $2.29 Billion
- Q4 2024
A detailed history of Shell Asset Management CO transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 12,554 shares of ARCT stock, worth $161,193. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,554
Previous 12,554
-0.0%
Holding current value
$161,193
Previous $291,000
26.8%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ARCT
# of Institutions
168Shares Held
26MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$60.3 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$34 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$26.5 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$26.5 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$24.8 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $341M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...